Design
Editorial
Answers are grounded in this paper and cite their sources.
Highlights the need for individualized management strategies, potentially integrating machine learning, to improve prognosis in decompensated heart failure.
Heart failure (HF) remains an extremely severe disease despite pharmacological innovation (1) as well as devices that are largely used. Still HF is a diagnosis associated with a mortality greater than most cancers (2). A large effort is thus, still, required to define best the strategies and the individualized managements that are supposed to improve the prognostic of the disease for any single patient with his co-morbidities and specificities.
No takes yet. Share an insight, caveat, or question.
Erwan Donal (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: